Fibrosis progression in chronic hepatitis C patients with occult hepatitis B co-infection

Journal of Clinical Virology

Volumn 35, Issue 2, 2006, Pages 185-192

  Hui, Chee Kin ^a   Lau, Eva ^b   Wu, Helen ^c   Monto, Alexander ^b   Kim, Michael ^b   Luk, John M ^a   Lau, George K K ^a   Wright, Teresa Lyn ^b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Roche Diagnostics   (United States)

Author keywords

Chronic hepatitis B infection; Chronic hepatitis C infection; Liver cirrhosis; Occult hepatitis B infection

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; VIRUS DNA;

ADULT; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIVER BIOPSY; LIVER FIBROSIS; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

DISEASE PROGRESSION; DNA, VIRAL; FIBROSIS; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS C, CHRONIC; HUMANS; RETROSPECTIVE STUDIES;

EID: 30144442788     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2005.07.003     Document Type: Article

References (37)

1. P. Bedossa, P. Bioulac-Sage, P. Callard, M. Chevallier, C. Degott, and Y. Deugnier The French METAVIR Cooperative Study Group Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C Hepatology 20 1994 15 20
2. P. Bedossa, and T. Poynard fort he METAVIR Cooperative Study Group An algorithm for the grading of activity in chronic hepatitis C Hepatology 24 1996 289 293
3. H.E. Blum, E. Galun, T.J. Liang, F. von Weizsacker, and J.R. Wands Naturally occuriing missense mutation in the polymerase gene terminating hepatitis B virus replication J Virol 65 1991 1836 1842
4. I. Cacciola, T. Pollicino, G. Squadrito, G. Cerenzia, M.E. Orlando, and R. Raimondo Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease N Engl J Med 341 1999 222 226
5. W.F. Carman, F.J. Van Deursen, L.T. Mimms, D. Hardie, R. Coppola, and R. Decker The prevalence of surface antigen variants of hepatitis B virus in Papua New Guinea South Africa and Sardinia Hepatology 26 1997 1658 1666
6. L. Castera, J. Vergniol, J. Foucher, B. Le Bail, E. Chanteloup, and M. Haaser Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C Gastroenterology 128 2005 343 350
7. I. Chemin, F. Zoulim, P. Merle, A. Arkhis, M. Chevallier, and A. Kay High incidence of hepatitis B infections among chronic hepatitis cases of unknown aetiology J Hepatol 34 2001 447 454
8. M. Damen, P. Sillekens, M. Sjerps, R. Meisert, I. Frantzen, and H.W. Reesink Stability of hepatitis C virus RNA during specimen handling and storage prior to NASBA amplification J Virol Methods 72 1998 175 184
9. N. De Maria, A. Colantoni, L. Friedlander, G. Leandro, R. Idilman, and J. Harig The impact of previous HBV infection in patients with chronic hepatitis C Am J Gastroenterol 95 2000 3529 3536
10. P. Fabris, D. Brown, G. Tositti, L. Bozzola, M.T. Giordani, and P. Bevilacqua Occult hepatitis B infection does not affect liver histology or response to therapy with interferon alpha and ribavirin in intravenous drug users with chronic hepatitis C J Clin Virol 29 2004 160 166
11. G. Fattovich, A. Tagger, L. Brollo, G. Giustina, P. Pontisso, and G. Realdi Hepatitis C virus infection in chronic hepatitis B virus carriers J Infect Dis 163 1991 400 402
12. R. Fukuda, N. Ishimura, M. Niigaki, S. Hamamoto, S. Satoh, and S. Tanaka Serologically silent hepatitis B virus co-infection in patients with hepatitis C virus-associated chronic liver disease; clinical and virological significance J Med Virol 58 1999 201 207
13. S.P. Georgiadou, K. Zachou, E. Rigopoulou, C. Liaskos, P. Mina, and F. Gerovasilis Occult hepatitis B virus infection in Greek patients with chronic hepatitis C and in patients with diverse nonviral hepatic diseases J Viral Hepatol 11 2004 358 365
14. E.R. Grumayer, S. Panzer, P. Ferenci, and H. Gardner Recurrence of hepatitis B in children with serologic evidence of past hepatitis B virus infection undergoing antileukemic chemotherapy J Hepatol 8 1989 232 235
15. J.H. Kao, P.J. Chen, M.Y. Lai, and D.S. Chen Occult hepatitis B virus infection and clinical outcomes of patients with chronic hepatitis C J Clin Microbiol 40 2002 4068 4071
16. M. Krajden, L. Comanor, O. Rifkin, A. Grigoriew, J.M. Minor, and G.F. Kapke Assessment of hepatitis B virus DNA stability in serum by the Chiron Quantiplex branched-DANN assay J Clin Microbiol 36 1998 382 386
17. M. Krajden, J.M. Minor, O. Rifkin, and L. Comanor Effect of multiple freeze-thaw cycles on hepatitis B virus DNA and hepatitis C virus RNA quantification as measured with branched-DNA technology J Clin Microbiol 37 1999 1683 1686
18. S. Kwok, and R. Higushi Avoiding false positives with PCR Nature 339 1989 237 238
19. T.J. Liang, H.E. Blum, and J.R. Wands Characterization and biological properties of a hepatitis B virus isolated from a patient without hepatitis B serologic markers Hepatology 12 1990 204 212
20. Y.D. Lo, W.Z. Mehal, and K.A. Fleming False-positive results and the polymerase chain reaction Lancet ii 1988 679
21. A.S. Lok, Liang RHS, E.K. Chiu, K.L. Wong, T.K. Chan, and D. Todd Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy Gastroenterology 100 1991 182 188
22. T.I. Michalak, C. Pasquinelli, S. Guilhot, and F.V. Chisari Hepatitis B virus persistence after recovery from acute viral hepatitis J Clin Invest 93 1994 230 239
23. A. Monto, J. Alonzo, J.J. Watson, Grunfeld, and T.L. Wright Steatosis in chronic hepatitis C: relative contributions of obesity, diabetes mellitus and alcohol Hepatology 36 2002 729 736
24. K. Nirei, M. Kaneko, M. Moriyama, and Y. Arakawa The clinical features of chronic hepatitis C are not affected by coexistence of hepatitis B virus DNA in patients negative for hepatitis B surface antigen Intervirology 43 2000 95 101
25. A. Penna, M. Artini, A. Cavali, M. Levrero, A. Bertoletti, and M. Pilli Long lasting T-cell responses following self-limited acute hepatitis B J Clin Invest 98 1996 1185 1194
26. T. Pollicino, G. Squadrito, G. Cerenzia, I. Cacciola, G. Raffa, and G. Raffa Hepatitis B virus maintains its proto-oncogenic properties in the case of occult HBV infection Gastroenterology 126 2004 347 350
27. T. Poynard, P. Bedossa, and P. Opolon Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR CLINIVIR and DOSVIRC groups Lancet 349 1997 825 832
28. T. Poynard, P. Mathurin, C.L. Lai, D. Gudayer, R. Poupon, and M.H. Tainturier A comparison of fibrosis progression in chronic liver diseases J Hepatol 38 2003 257 265
29. E. Sagnelli, N. Coppola, C. Scolastico, A.R. Mogavero, P. Filippini, and F. Piccinino HCV genotype and "silent" HBV co-infection: two main risk factors for a more severe liver disease J Med Virol 64 2001 350 355
30. M. Shindo, T. Okuno, K. Arai, M. Matsumoto, M. Takeda, and K. Kashima Detection of hepatitis B virus DNA in paraffin-embedded liver tissues in chronic hepatitis B or non-A, non-B hepatitis using polymerase chain reaction Hepatology 13 1991 167 171
31. J. Stransky, L. Malina, B. Cieslarova, J. Striesky, I. Putova, and J. Horak Overt and hidden co-infection with hepatitis B and C viruses in chronic liver disease and porphyria cutanea tarda Acta Virol 44 2000 23 28
32. V. Thiers, E. Nakajima, D. Kremsdorf, D. Mack, H. Schellekens, and F. Driss Transmission of hepatitis B from hepatitis-B-seronegative subjects Lancet 2 1988 1273 1276
33. M. Torbenson, R. Kannangai, J. Astemborski, S.A. Strathdee, D. Vlahov, and D.L. Thomas High prevalence of occult hepatitis B in Baltimore injection drug users Hepatology 39 2004 51 57
34. E. Villa, A. Grottola, P. Buttafoco, P. Trande, A. Merighi, and N. Fratti Evidence for hepatitis B virus infection in patients with chronic hepatitis C with and without serological markers of hepatitis B Dig Dis Sci 40 1995 8 13
35. J. Waite, R.J.C. Gilson, I.V.D. Weller, C.J. Lacey, M.H. Hambling, and A. Hawkins Hepatitis B virus reactivation or reinfection associated with HIV-1 infection AIDS 2 1988 443 448
36. K. Yamamoto, M. Horikita, F. Tsuda, K. Itoh, Y. Akahane, and S. Yotsumoto Naturally occurring escape mutants of hepatitis B virus with various mutations in the S gene in carriers seropositive for antibody to hepatitis B surface antigen J Virol 68 1994 2671 2676
37. Y.Y. Zhang, B.G. Hansson, L.S. Kuo, A. Widell, and E. Nordenfelt Hepatitis B virus DNA in serum and liver is commonly found in Chinese patient with chronic liver disease despite the presence of antibodies to HBsAg Hepatology 17 1993 538 544